Sinofn Health
Sinofn Health
At SINOFN Health, we redefine the "Private Label" landscape. In an era where consumers demand "Information Gain", our manufacturing philosophy transcends basic OEM. We provide end-to-end scientific validation, sourcing premium bioactive compounds, and ensuring clinical-grade bioavailability in every unit.
The global probiotic market is shifting from "general wellness" to "targeted functional nutrition." Our partners require more than just capsules; they require delivery systems that ensure survivability and colonization. SINOFN leverages advanced micro-encapsulation technology to ensure our strains remain viable throughout the shelf life, catering to the growing consumer demand for clinically backed supplements.
As a leading Chinese manufacturer backed by the Chinese Academy of Sciences, we bridge the gap between Asian innovation and Western quality standards. We handle the complex compliance landscape (FDA, EFSA, GMP) so your brand can launch with confidence. Our macro-solutions cover bulk raw materials, white-label packaging, and custom formulation development.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU children. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods. Today, her legacy powers a global platform for nutraceutical innovation.
Our R&D team is led by top-tier talent: Dr. Tan Shengjie (Peking University Medical School) and Dr. Zhang Ying (CAS Postdoc). With Hans van Dijk (Netherlands) leading our EU regulatory compliance and delivery tech, we ensure that every product we manufacture meets global pharmaceutical standards.
Optimizing strain efficacy for specific health outcomes, from gut-brain axis to immunity.
Moving beyond standard pills to delayed-release capsules and high-stability powder blends.
Full support for labeling, regulatory filings, and market-specific dietary requirements.
m² Factory Floor
RMB Capital
Key Patents
Registered Trademarks
A: We utilize GMP-certified production lines with ISO 22000 and FSSC 22000 certifications. Every batch undergoes rigorous HPLC/GC-MS testing to ensure purity and potency before leaving our facility.
A: Absolutely. We offer scalable MOQ (Minimum Order Quantity) solutions and pilot-scale prototyping to help startups enter the market with low entry barriers while maintaining premium quality.
A: Our partnership with the Chinese Academy of Sciences allows us to offer custom formulation development, stability testing, and bioavailability optimization that few contract manufacturers can match.
